Translational Development Acquisition Corp. - Class A Common Stock (TDAC)

CUSIP: G9008W105

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 6 signals
Share change
+770,803
SEC-reported price per share
$10.49
Number of holders
43
Value change
+$8,075,273
Number of buys
9
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
14,657,097

Security key

G9008W105

Report period

Q4 2025

Institutions

43

Top holders

10

Ownership snapshot

Top reported holders of TDAC - Translational Development Acquisition Corp. - Class A Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Magnetar Financial LLC
Disclosed value leader
WOLVERINE ASSET MANAGEMEN...
Comparable rows
4/15
Latest evidence
30 Sep 2025
13F 13D/G Lead comparable stake: 7.5% 11 rows are not safely comparable across share classes. 13D/G row: Magnetar Financial LLC Showing 1-6 of 15 holder rows.

Quick read

Magnetar Financial LLC leads the comparable SEC ownership view at 7.5%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Magnetar Financial LLC's linked filing trail.
Comparable ownership Top 4
Magnetar Financial LLC 7.5%
AQR CAPITAL MANAGEMENT LLC 6.4%
BANK OF MONTREAL /CAN/ 4.6%
HEALTHCARE OF ONTARIO PENSION PLA... 2.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Magnetar Financial LLC
13F 13D/G
Company
7.5%
Reported 13D/G · 31 Dec 2024
$13,650,000
1,950,000 shares
mixed-class rows
— 30 Sep 2025
AQR CAPITAL MANAGEMENT LLC
13D/G
6.4%
Reported 13D/G · 31 Mar 2025
$11,087,889
1,099,989 shares
-$3,880,911 31 Mar 2025
BANK OF MONTREAL /CAN/
13D/G
Bank of Montreal
4.6%
Reported 13D/G · 30 Jun 2025
$8,240,000
800,000 shares
-$2,060,000 30 Jun 2025
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
13D/G 13F
Company
2.3%
Reported 13D/G · 31 Mar 2025
$4,032,000
400,000 shares
-$5,040,000 31 Mar 2025
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
13F
—
mixed-class rows
$16,158,038
1,700,937 shares
mixed-class rows
— 30 Sep 2025
AQR Arbitrage LLC
13F
Company
13F
—
mixed-class rows
$11,502,364
1,646,981 shares
mixed-class rows
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
43
Shares
15,977,751
Rows available
43
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
40
Q4 2025 holders
43
Holder diff
3
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .